| 摘要 |
<p>The present invention relates to a pharmaceutical composition containing resveratrol as an active ingredient for treating and preventing arthritis and, more specifically, to a pharmaceutical composition having the expression of COX-2 reduced and increasing the expression of type 2 collagen. The pharmaceutical composition containing resveratrol as an active ingredient for treating and preventing arthritis comprises resveratrol and a p38 mitogen-activated protein kinase (p38 MAP kinase; p38 kinase) activity inhibitor.</p> |
